超越度:解读粘弹性在癌症演变和治疗反应中的作用
Ana Zubiarrain-Laserna1,2,3, Daniel Martínez-Moreno2,3,4,5, Julia López de Andrés2,3,4,5,6
1Leartiker S. Coop., Xemein Etorbidea 12A, 48270 Markina-Xemein, Spain.
Biofabrication
|June 11, 2024
概括
癌症的进展与组织粘性弹性有关,而不仅仅是性. 了解这种关系和开发新的机械生物标志物对于临床应用至关重要.
科学领域:
- 生物物理学的生物物理.
- 癌症生物学 癌症生物学
- 生物材料是一种生物材料.
背景情况:
- 癌症的进展越来越多地与组织粘性弹性有关,这挑战了传统上对硬度的关注.
- 目前的临床应用主要利用组织弹性和性用于诊断,治疗和手术规划.
- 在了解粘性弹性在癌症中的作用方面存在差距,需要新的机械生物标志物.
研究的目的:
- 审查目前对癌症粘性弹性及其对进展的影响的理解.
- 突出临床试验,重点关注用于癌症诊断和监测的生物力学特性.
- 检查生物制造模型在研究细胞外矩阵 (ECM) 粘性弹性对癌症行为的影响中的使用.
主要方法:
- 关于癌症粘性弹性和生物物理信号的现有文献的综述.
- 对评估瘤生物机械性质的临床试验的分析.
- 检查基于水凝的体外平台和生物制造的瘤模型.
主要成果:
- 瘤细胞与生物物理信号相互作用,影响瘤粘性弹性和癌症进展.
- 临床试验主要使用弹性和刚性,忽视粘性弹性的潜力.
- 水凝平台允许系统地研究ECM粘性弹性对癌症的影响.
结论:
- 进一步了解粘性弹性在癌症中的作用对于开发新的诊断和治疗策略至关重要.
- 生物制造的瘤模型为研究ECM粘性弹性和癌症进展提供了一个有希望的途径.
- 未来的研究应该专注于机械评估的复杂,仿生模型.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cell-matrix's Response to Mechanical Forces
2.6K
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue.
Anchoring junctions mechanically attach a cell to the...
Anchoring junctions mechanically attach a cell to the...
2.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


